227 related articles for article (PubMed ID: 12652960)
21. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
Hanly JG; McCurdy G; Fougere L; Douglas JA; Thompson K
J Rheumatol; 2004 Nov; 31(11):2156-62. PubMed ID: 15517627
[TBL] [Abstract][Full Text] [Related]
22. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
[TBL] [Abstract][Full Text] [Related]
23. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.
Becker-Merok A; Nossent HC
J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708
[TBL] [Abstract][Full Text] [Related]
24. Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.
Nossent J; Cikes N; Kiss E; Marchesoni A; Nassonova V; Mosca M; Olesinska M; Pokorny G; Rozman B; Schneider M; Vlachoyiannopoulos PG; Swaak A
Lupus; 2007; 16(5):309-17. PubMed ID: 17576731
[TBL] [Abstract][Full Text] [Related]
25. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of migraine in systemic lupus erythematosus: relation to cumulative organ damage.
Appenzeller S; Costallat LT
Cephalalgia; 2004 Dec; 24(12):1024-30. PubMed ID: 15566416
[TBL] [Abstract][Full Text] [Related]
27. Fibromyalgia is a major contributor to quality of life in lupus.
Gladman DD; Urowitz MB; Gough J; MacKinnon A
J Rheumatol; 1997 Nov; 24(11):2145-8. PubMed ID: 9375874
[TBL] [Abstract][Full Text] [Related]
28. Increased arterial stiffness correlated with disease activity in systemic lupus erythematosus.
Shang Q; Tam LS; Li EK; Yip GW; Yu CM
Lupus; 2008 Dec; 17(12):1096-102. PubMed ID: 19029277
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
Ward MM; Marx AS; Barry NN
J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
[TBL] [Abstract][Full Text] [Related]
30. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
[TBL] [Abstract][Full Text] [Related]
31. Cigarette smoking and disease activity in systemic lupus erythematosus.
Ghaussy NO; Sibbitt W; Bankhurst AD; Qualls CR
J Rheumatol; 2003 Jun; 30(6):1215-21. PubMed ID: 12784392
[TBL] [Abstract][Full Text] [Related]
32. Cigarette smoking and cutaneous damage in systemic lupus erythematosus.
Turchin I; Bernatsky S; Clarke AE; St-Pierre Y; Pineau CA
J Rheumatol; 2009 Dec; 36(12):2691-3. PubMed ID: 19884279
[TBL] [Abstract][Full Text] [Related]
33. [Poor prognosis factors in SLE: results of 5-year follow-up].
Sushchuk EA; Zborovskiĭ AB
Ter Arkh; 2009; 81(6):16-9. PubMed ID: 19663186
[TBL] [Abstract][Full Text] [Related]
34. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD
Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092
[TBL] [Abstract][Full Text] [Related]
35. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus.
Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED
Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232
[TBL] [Abstract][Full Text] [Related]
36. SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.
Laustrup H; Voss A; Green A; Junker P
Lupus; 2010 Mar; 19(3):239-46. PubMed ID: 19946037
[TBL] [Abstract][Full Text] [Related]
37. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
Ibañez D; Gladman D; Urowitz M
J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
[TBL] [Abstract][Full Text] [Related]
38. Aerobic capacity correlates to self-assessed physical function but not to overall disease activity or organ damage in women with systemic lupus erythematosus with low-to-moderate disease activity and organ damage.
Boström C; Dupré B; Tengvar P; Jansson E; Opava CH; Lundberg IE
Lupus; 2008 Feb; 17(2):100-4. PubMed ID: 18250132
[TBL] [Abstract][Full Text] [Related]
39. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
40. Early renal damage assessed by the SLICC/ACR damage index is predictor of severe outcome in lupus patients in Pakistan.
Rabbani MA; Habib HB; Islam M; Ahmad B; Shah SM; Tahir S; Merchant D; Ahmad A
Lupus; 2010 Nov; 19(13):1573-8. PubMed ID: 20705644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
